VERTEX PHARMACEUTICALVERTEX PHARMACEUTICALVERTEX PHARMACEUTICAL

VERTEX PHARMACEUTICAL

No trades
See on Supercharts
Market capitalization
‪1.74 T‬MXN
‪61.48 B‬MXN
‪167.12 B‬MXN
‪257.54 M‬
Beta (1Y)
0.94

About VERTEX PHARMACEUTICAL

CEO
Reshma Kewalramani
Headquarters
Boston
Website
Employees (FY)
‪5.4 K‬
Founded
1989
ISIN
US92532F1003
FIGI
BBG004PVSS21
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of VRTX is 6681.76 MXN — it has decreased by 0.32% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange VERTEX PHARMACEUTICAL stocks are traded under the ticker VRTX.
VERTEX PHARMACEUTICAL is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for VERTEX PHARMACEUTICAL has a max estimate of 9801.75 MXN and a min estimate of 5549.77 MXN.
VRTX earnings for the last quarter are 71.12 MXN whereas the estimation was 68.57 MXN which accounts for 3.72% surprise. Estimated earnings for the next quarter are 69.08 MXN. See more details about VERTEX PHARMACEUTICAL earnings.
VERTEX PHARMACEUTICAL revenue for the last quarter amounts to ‪43.29 B‬ MXN despite the estimated figure of ‪43.60 B‬ MXN. In the next quarter revenue is expected to reach ‪42.68 B‬ MXN.
Yes, you can track VERTEX PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
Like other stocks, VRTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VERTEX PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
VRTX reached its all-time high on Jan 23, 2024 with the price of 7607.96 MXN, and its all-time low was 808.03 MXN and was reached on Apr 14, 2014.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪5.40 K‬ employees. See our rating of the largest employees — is VERTEX PHARMACEUTICAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VERTEX PHARMACEUTICAL EBITDA is ‪67.13 B‬ MXN, and current EBITDA margin is 45.32%. See more stats in VERTEX PHARMACEUTICAL financial statements.